ES2169497T3 - Derivados de celulosa. - Google Patents

Derivados de celulosa.

Info

Publication number
ES2169497T3
ES2169497T3 ES98903269T ES98903269T ES2169497T3 ES 2169497 T3 ES2169497 T3 ES 2169497T3 ES 98903269 T ES98903269 T ES 98903269T ES 98903269 T ES98903269 T ES 98903269T ES 2169497 T3 ES2169497 T3 ES 2169497T3
Authority
ES
Spain
Prior art keywords
sup
percent
weight
polymeric chain
microdispersed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98903269T
Other languages
English (en)
Inventor
Ivan Santar
Frantisek Kiss
Jiri Briestensky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpenstock Holdings Ltd
Original Assignee
Alpenstock Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpenstock Holdings Ltd filed Critical Alpenstock Holdings Ltd
Application granted granted Critical
Publication of ES2169497T3 publication Critical patent/ES2169497T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C08B15/04—Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

LA INVENCION SE REFIERE A ACIDO POLIANHIDROGLUCURONICO MICRODISPERSADO ESTABLE Y A SALES DEL MISMO, QUE CONTIENEN EN SU CADENA POLIMERICA DEL 8 AL 30 % EN PESO DE GRUPOS CARBOXILO, SIENDO AL MENOS EL 80 % EN PESO DE DICHOS GRUPOS DE TIPO URONICO, E INCLUYENDO COMO MAXIMO EL 5 % EN PESO DE DICHOS GRUPOS CARBOXILO, GRUPOS 2,6 Y 3,6 HEMIACETALES INTRA- E INTERMOLECULARES, 2,4 - HEMIALDALES Y ALDEHIDOS C 2 C 3 . LA MASA M OLECULAR DE LA CADENA POLIMERICA ES DE 1 X 10 3 A 3 X 10 SUP,5 DALTONS. LOS PRODUCTOS MICRODISPERSADOS SE PREPARAN SOMETIENDO UN MATERIAL QUE CONTIENE ACIDO POLIANHIDROGLUCURONICO A UNA HIDROLISIS PARCIAL O TOTAL Y A NEUTRALIZACION EN MEDIO OXIDATIVO.
ES98903269T 1997-01-30 1998-01-30 Derivados de celulosa. Expired - Lifetime ES2169497T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE970061 1997-01-30

Publications (1)

Publication Number Publication Date
ES2169497T3 true ES2169497T3 (es) 2002-07-01

Family

ID=11041361

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98903269T Expired - Lifetime ES2169497T3 (es) 1997-01-30 1998-01-30 Derivados de celulosa.

Country Status (14)

Country Link
US (4) US6372718B2 (es)
EP (1) EP0956305B1 (es)
JP (1) JP4362620B2 (es)
AT (1) ATE209661T1 (es)
AU (1) AU726617B2 (es)
CA (1) CA2279649C (es)
DE (1) DE69802666T2 (es)
DK (1) DK0956305T3 (es)
ES (1) ES2169497T3 (es)
GB (1) GB2335921B (es)
IE (1) IE980056A1 (es)
PT (1) PT956305E (es)
WO (1) WO1998033822A1 (es)
ZA (1) ZA98783B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033822A1 (en) * 1997-01-30 1998-08-06 Alpenstock Holdings Limited Cellulose derivatives
EP1098640A1 (en) 1998-07-21 2001-05-16 Alpenstock Holdings Limited Anti-ulcer composition comprising a polysaccharide containing glucuronic acid
US6060461A (en) * 1999-02-08 2000-05-09 Drake; James Franklin Topically applied clotting material
WO2003068245A1 (en) * 2002-02-14 2003-08-21 Alpenstock Holdings Limited Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator
US20060008505A1 (en) * 2004-07-08 2006-01-12 Brandon Gerard J Product
US20070026052A1 (en) * 2005-07-28 2007-02-01 Baggett Richard W Hemostatic material
WO2007026341A1 (en) * 2005-09-02 2007-03-08 Alltracel Development Services Limited A method for preparing polyanhydroglucuronic acid and/or salts thereof
US9095603B2 (en) * 2006-04-05 2015-08-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anti-allergy compositions
WO2008010199A2 (en) * 2006-07-18 2008-01-24 Nanopeutics S.R.O. A nanofibre product
WO2009060140A2 (fr) * 2007-08-31 2009-05-14 Greentech Composition cosmetique comprenant un ou plusieurs composes de type beta- ( 1, 3 ) -glucuronane ou beta- ( 1, 3 ) -glucoglucuronane
EP2216345B1 (en) * 2007-11-26 2014-07-02 The University of Tokyo Cellulose nanofiber, production method of same and cellulose nanofiber dispersion
US20090312537A1 (en) * 2008-04-30 2009-12-17 Xyleco, Inc. Carbohydrates
WO2010086616A1 (en) 2009-01-30 2010-08-05 Hemcon Medical Technologies (Ip) Ltd Micronized oxidized cellulose salt
JP2010202856A (ja) * 2009-02-06 2010-09-16 Kao Corp セルロース繊維の懸濁液とその製造方法
JP5330882B2 (ja) * 2009-03-30 2013-10-30 日本製紙株式会社 セルロースゲル分散液の製造方法
EP2575907B1 (en) * 2010-06-03 2015-07-29 Hemcon Medical Technologies (IP) Limited A surgical gel system
KR102151693B1 (ko) * 2014-08-29 2020-09-03 닛폰세이시가부시키가이샤 위생 박엽지 및 그것을 이용한 흡수성 물품
JP6469421B2 (ja) * 2014-11-14 2019-02-13 日本製紙クレシア株式会社 吸収性物品
CN104945448B (zh) * 2015-05-22 2018-06-19 上海绿谷制药有限公司 一种氧化型β-1,4-寡聚葡萄糖醛酸及其制备方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB709684A (en) 1951-09-21 1954-06-02 Nyma Kunstzijdespinnerij Nv Improvements in or relating to the oxidation of cellulose
BE527849A (es) 1953-04-19
DE941289C (de) 1953-06-10 1956-04-05 Dr Hellmut Bredereck Verfahren zur Herstellung von Purin
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
GB1049636A (en) * 1963-02-01 1966-11-30 Kurashiki Rayon Kk Method of manufacturing oxycellulose powder
GB1457885A (en) * 1973-03-29 1976-12-08 Gallaher Ltd Oxidation of cellulose
GB1593513A (en) 1977-10-01 1981-07-15 Statni Vyzkumny Ustav Textilni Method of preparing oxidized cellulose and salts thereof
SU937462A1 (ru) 1980-12-15 1982-06-23 Научно-исследовательский институт физико-химических проблем Белорусского государственного университета им.В.И.Ленина Способ получени окисленной целлюлозы
US4347057A (en) 1981-03-05 1982-08-31 Yasnitsky Boris G Method of making absorbable surgical sutures
US5180398A (en) 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
US5405953A (en) * 1993-08-03 1995-04-11 Biocontrol Incorporated Microfibrillated oxycellulose
JP3477849B2 (ja) * 1994-09-30 2003-12-10 日本ゼオン株式会社 ニトリル基含有高飽和共重合体ゴムとエチレン系飽和型共重合体ゴムとからなるゴム組成物
ATE290368T1 (de) * 1997-01-30 2005-03-15 Alltracel Dev Services Ltd Blutstillende aerosol-zubereitung
WO1998033822A1 (en) * 1997-01-30 1998-08-06 Alpenstock Holdings Limited Cellulose derivatives

Also Published As

Publication number Publication date
US20070036730A1 (en) 2007-02-15
US20010014318A1 (en) 2001-08-16
CA2279649C (en) 2007-04-10
ZA98783B (en) 1998-08-17
DK0956305T3 (da) 2002-01-07
GB2335921B (en) 2000-08-02
WO1998033822A1 (en) 1998-08-06
ATE209661T1 (de) 2001-12-15
US6372718B2 (en) 2002-04-16
AU726617B2 (en) 2000-11-16
PT956305E (pt) 2002-05-31
DE69802666D1 (de) 2002-01-10
GB9916279D0 (en) 1999-09-15
AU6004398A (en) 1998-08-25
JP2001509199A (ja) 2001-07-10
GB2335921A (en) 1999-10-06
EP0956305A1 (en) 1999-11-17
US20010009902A1 (en) 2001-07-26
CA2279649A1 (en) 1998-08-06
IE980056A1 (en) 2000-02-09
US20030077231A1 (en) 2003-04-24
DE69802666T2 (de) 2002-05-08
EP0956305B1 (en) 2001-11-28
JP4362620B2 (ja) 2009-11-11

Similar Documents

Publication Publication Date Title
ES2169497T3 (es) Derivados de celulosa.
SE9504495D0 (sv) Linjär blockpolymer innefattande urea- och uretangrupper, förfarande för framställning av linjära blockpolymerer samt användning av blockpolymererna som implantat
ATE38841T1 (de) Geformter artikel aus hyaluronsaeure und verfahren zu seiner herstellung.
FI955320A (fi) Bioaktiivisia ja/tai kohdennettuja dendriimikonjugaatteja
ATE114322T1 (de) Ester von polysacchariden.
CA2399039A1 (en) Hyaluronic acid gel, method of its production and medical material containing it
FI900188A0 (fi) Tvaerbundna karboxipolysackarider.
ATE318848T1 (de) Superabsorbierende gele aus poly(vinylamin) und verfahren zur herstellung davon
ATE168889T1 (de) Bioresorbierbares material und aus diesem material hergestellter gegenstand
BR9708439A (pt) Polímeros temporariamente resistentes a molhado provenientes de produtos de reacão
RU94045151A (ru) Биоразлагаемые полимеры и способ их получения
TR199901334A2 (xx) Sa� muamelesi i�in maddeler ve bu maddelerin bile�imleri.
DE69806468D1 (de) Glykosaminoglykane mit hoher antithrombotischer wirkung
ATE290564T1 (de) Funktionsfähige poly-alpha-aminosäurederivate zur modifizierung von biologisch wirksamen stoffen und deren herstellung
SE9502486D0 (sv) Absorbentmaterial därav framställd absorbentkropp och sätt vid beredning av materialet
DE69112420D1 (de) Makromolekulare monomere aus lebenden polymeren.
ATE196478T1 (de) Thermoplastische biologisch abbaubare polysaccharidderivate, verfahren zu ihrer herstellung und ihre verwendung
DE69833487D1 (de) Polymer-wirkstoff-konjugate zur behandlung von krebs
MX9701609A (es) Composicion espesada por un alquileter de polisacarido.
NO934044D0 (no) Genetisk kontroll av acetylering op pyruvylering av xantanbaserte polysakkaridpolymerer
TR199902868T2 (xx) Bir g�da asidinin �retimi.
NO996212D0 (no) Polymer blanding med hoey transparens
DE69712887D1 (de) Pektin geliermittel
DE69032707D1 (de) Genetische Kontrolle zur Acetylierung und Pyruvylierung von Xanthangummi
ATE388169T1 (de) Niedermolekulare polysaccharide mit antithrombotischer wirkung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 956305

Country of ref document: ES